Fermenta Biotech Q2 FY27: revenue up 0.1% to ₹136 Cr, net profit down 48.0% to ₹9 Cr
Results · Finvezto · 5 Nov 2026 · Fermenta Biotech (FERMENTA)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 136 | - | +0.1% |
| Operating profit | 23 | - | -28.0% |
| Net profit | 9 | -1.1% | -48.0% |
| Operating margin | 17.1% | - | -6.7 pp |
| Net margin | 6.9% | - | -6.4 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Fermenta Biotech reported Q2FY27 consolidated revenue of Rs 135.8 crore (up 0.1% YoY), EBITDA of Rs 23.2 crore (down 28% YoY), and net profit of Rs 9.4 crore (down 48% YoY). NSE filing
- Half-year performance was impacted by lower animal nutrition pricing and volumes alongside non-recurring income in the prior-year base period. NSE filing
- Revenue was ₹136 Cr, up 0.1% on a year earlier. Finvezto data
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.